Radwan Massoud

Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms‐like tyrosine kinase 3‐mutated acute myeloid leukemia

Giorgia Battipaglia, Annalisa Ruggeri, Radwan Massoud et al. · Cancer · 2017 · 107 citations · Full text

Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation

Radwan Massoud, Nico Gagelmann, Ulrike Fritzsche‐Friedland et al. · Haematologica · 2021 · 67 citations · Full text

Cell Therapy, Gvhd Prophylaxis, Immunology +20

Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness

Meaghan Boileau, Margret Shirinian, Tenzin Gayden et al. · Nature Communications · 2019 · 47 citations · Full text

Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphoma

Jean El Cheikh, Radwan Massoud, Basel Haffar et al. · Bone Marrow Transplantation · 2017 · 42 citations · Full text

Lymphoid Neoplasia, Cell Therapy, Hodgkin Lymphoma +11

Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT

Jean El Cheikh, Radwan Massoud, Elie-Jacques Fares et al. · Bone Marrow Transplantation · 2017 · 40 citations

Preventive Therapy, Oncology, Pharmacology +3